journal article·2025-11-19Open access

Shortened Acquisition Duration for Brain Tumor 11C-Methionine Positron Emission Tomography on Silicon Photomultiplier Positron Emission Tomography/Computed Tomography

Takato Inomata, Kaoru Sato, Masanobu Ibaraki, Mamoru Kominami, Yuki Shinohara, Fumiko Kinoshita, Hiroyuki Yamamoto, Mamoru Kato, Toshibumi Kinoshita, Koichi Chida

Applied Sciences· Volume 15· Issue 22

Abstract

Positron emission tomography/computed tomography (PET/CT) scanners equipped with silicon photomultiplier detectors offer superior sensitivity and count-rate performance. The aim of this study was to evaluate the feasibility and impact of shortening the acquisition duration in brain tumor 11C-methionine PET using a silicon photomultiplier PET/CT system, and to assess how point spread function (PSF) correction influences quantitative values. In the phantom study, a brain tumor phantom was scanned using the Biograph Vision silicon photomultiplier-based PET/CT system. Data were acquired for 10, 5, 3, and 1 min, and the images were reconstructed with and without PSF correction. In the clinical study, 20 patients who underwent 11C-methionine PET were retrospectively analyzed. PET data were acquired over 10 min and subsequently reconstructed for 10, 5, and 3 min. We evaluated quantitative parameters including the maximum standardized uptake value (SUVmax), and their relative errors under shortened acquisition durations were analyzed. In the phantom study, the SUVmax increased with shorter acquisition durations; however, this increase was less pronounced with PSF correction. In the clinical study, relative errors of SUVmax for the 5 and 3 min acquisitions with PSF correction were 2.9 ± 3.8% and 5.2 ± 5.4%, respectively. They were smaller than those without PSF correction (5.5 ± 5.1% and 12.7 ± 8.5%), indicating superior quantitative stability with shortened acquisition duration. The combination of the Biograph Vision system and PSF correction enabled the acquisition of high-quality PET images with shortened scan times.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Medical Imaging Techniques and Applications · Radiation Detection and Scintillator Technologies · Glioma Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels-Akita, 6-10 Senshu-Kubota-Machi, Akita 010-0874, Japan

Course of Radiological Technology, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo, Aoba-ku, Sendai 980-8575, Japan

Department of Radiation Disaster Medicine, International Research Institute of Disaster Science, Tohoku University, 468-1 Aramaki Aza-Aoba, Aoba-ku, Sendai 980-0845, Japan

Funding

NRA Human Resource Development, Human Resource Development Program for Advanced Radiation Protection with Practical Problem-Solving Skills in Japan

References (55)

Show source-provided references
1. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas10.1007/s11307-007-0115-2 ↗
2. A meta-analysis on the diagnostic performance of 18F-FDG and 11C-methionine PET for differentiating brain tumors10.3174/ajnr.A3718 ↗
3. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET10.1007/s00259-001-0690-4 ↗
4. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas
5. Stefano, A., Leal, A., Richiusa, S., Trang, P., Comelli, A., Benfante, V., Cosentino, S., Sabini, M.G., Tuttolomondo, A., and Altieri, R. (2021). Robustness of PET radiomics features: Impact of co-registration with MRI. Appl. Sci., 11.10.3390/app112110170 ↗
6. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas10.1093/neuonc/now058 ↗
7. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence
8. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: Is a differential diagnosis possible?10.3171/jns.2003.98.5.1056 ↗
9. 11C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases10.1259/bjr.20210275 ↗
10. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases10.1097/RLU.0000000000000561 ↗
11. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: Insight from a PET and MR fusion image study10.1136/jnnp.2003.028480 ↗
12. Surgical target selection in cerebral glioma surgery: Linking methionine (MET) PET image fusion and neuronavigation10.1055/s-2007-991143 ↗
13. Aiming for [18F]FDG-PET acquisition time reduction in clinical practice for neurological patients10.1016/j.ejmp.2023.102604 ↗
14. 18F-NaF PET/CT of obese patients on a lutetium-yttrium oxyorthosilicate PET/CT system: Patient dosimetry, optimization of injected activity, and acquisition time10.2967/jnmt.120.258137 ↗
15. Optimization of intraventricular radioactive concentration for 13N ammonia PET with time-of-flight scanner: Simplified phantom study with noise equivalent count rate analysis10.17996/anc.23-00178 ↗
16. Japanese Society of Nuculear Medicine (2017). Standard PET Imaging Protocols and Phantom Test Procedures and Criteria: Executive Summary, Japanese Society of Nuclear Medicine. Available online: https://jsnm.org/wp_jsnm/wp-content/themes/theme_jsnm/doc/StandardPETProtocolPhantom20170201.pdf.
17. Performance characteristics of the digital Biograph Vision PET/CT system10.2967/jnumed.118.215418 ↗
18. Image quality and semiquantitative measurements on the Biograph Vision PET/CT system: Initial experiences and comparison with the Biograph mCT10.2967/jnumed.119.227801 ↗
19. From a PMT-based to a SiPM-based PET system: A study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 45010.1186/s40658-020-00323-w ↗
20. Image quality and qctivity optimization in oncologic 18F-FDG PET using the digital Biograph Vision PET/CT System10.2967/jnumed.119.234351 ↗
21. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT10.1007/s12149-021-01588-6 ↗
22. Weber, M., Jentzen, W., Hofferber, R., Herrmann, K., Fendler, W.P., Rischpler, C., Umutlu, L., Conti, M., Costa, P.F., and Sraieb, M. (2021). Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision. BMC Cancer, 21.10.1186/s12885-020-07723-2 ↗
23. Evaluation of low-dose whole-body FDG PET with SiPM-based PET/CT Scanner: Visual and semi-quantitative analyses using random sampling from full-dose scan data (in Japanese)10.6009/jjrt.2023-1365 ↗
24. Effect of quantitative values on shortened acquisition duration in brain tumor 11C-methionine PET/CT10.1186/s40658-021-00379-2 ↗
25. Quantification of the impact of TOF and PSF on PET images using the noise-matching concept: Clinical and phantom study10.1007/s41365-017-0308-6 ↗
26. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters10.2967/jnumed.112.103861 ↗
27. Gibbs artifact reduction by nonnegativity constraint10.2967/jnmt.110.086439 ↗
28. Noise and edge artifacts in maximum-likelihood reconstructions for emission tomography10.1109/TMI.1987.4307831 ↗
29. Harmonizing SUVs in multicentre trials when using different generation PET systems: Prospective validation in non-small cell lung cancer patients10.1007/s00259-013-2391-1 ↗
30. Edge artifacts in point spread function-based PET reconstruction in relation to object size and reconstruction parameters
31. The added prognostic value of metabolic tumor size on FDG-PET at first suspected recurrence of glioblastoma multiforme10.1111/jon.12386 ↗
32. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group10.1200/JCO.1988.6.2.338 ↗
33. Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of Grade II Glioma10.1097/MD.0000000000024850 ↗
34. Diagnostic and prognostic value of 11C-Methionine PET for nonenhancing gliomas10.3174/ajnr.A4460 ↗
35. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas10.1093/neuonc/noac040 ↗
36. Nakajo, K., Uda, T., Kawashima, T., Terakawa, Y., Ishibashi, K., Tsuyuguchi, N., Tanoue, Y., Nagahama, A., Uda, H., and Koh, S. (2022). Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma. Sci. Rep., 12.10.1038/s41598-021-04216-5 ↗
37. Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: Comparison with an MR-based method in FDG imaging10.1007/s12149-022-01753-5 ↗
38. Arrival time mapping with 15O-gas PET for cerebrovascular steno-occlusive diseases: A comparative study with CT perfusion10.1186/s13550-025-01209-7 ↗
39. Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner10.1007/s12149-023-01886-1 ↗
40. AMIDE: A free software tool for multimodality medical image analysis10.1162/153535003322556877 ↗
41. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: Local comparison with stereotactic histopathology10.1158/1078-0432.CCR-04-0262 ↗
42. Prognostic value of metabolic tumor volume on 11C-Methionine PET in predicting progression-free survival in high-grade glioma10.1007/s13139-015-0362-0 ↗
43. Initial experience with a SiPM-based PET/CT scanner: Influence of acquisition time on image quality10.1186/s40658-018-0207-x ↗
44. The measurement of observer agreement for categorical data10.2307/2529310 ↗
45. JASP Team (2025, October 23). JASP (Version 0.95.4) [Computer Software], Available online: https://jasp-stats.org/.
46. Evaluation of the accumulation of 11C-methionine with standardized uptake value in the normal brain10.2967/jnumed.109.068783 ↗
47. Noise considerations for PET quantification using maximum and peak standardized uptake value10.2967/jnumed.111.101733 ↗
48. Influence of statistical fluctuation on reproducibility and accuracy of SUVmax and SUVpeak: A phantom study10.2967/jnmt.115.161745 ↗
49. For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time10.1186/s13550-016-0177-8 ↗
50. Fujisawa, M., Haga, Y., Sota, M., Abe, M., Kaga, Y., Inaba, Y., Suzuki, M., Meguro, T., Hosoi, Y., and Chida, K. (2023). Evaluation of lens doses among medical staff involved in nuclear medicine: Current eye radiation exposure among nuclear-medicine staff. Appl. Sci., 13.10.3390/app13169182 ↗
51. Fujisawa, M., Sota, M., Haga, Y., Tanaka, S., Kataoka, N., Kato, T., Kaga, Y., Abe, M., Suzuki, M., and Inaba, Y. (2025). Real-time monitoring of occupational radiation exposure in nuclear medicine technologists: An initial study. Appl. Sci., 15.10.3390/app152011008 ↗
52. ICRP (2015). Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances. ICRP Publ., 44, 7–321.10.1177/0146645314558019 ↗
53. What are useful methods to reduce occupational radiation exposure among radiological medical workers, especially for interventional radiology personnel?10.1007/s12194-022-00660-8 ↗
54. Evaluation of radiation dose to the lens in interventional cardiology physicians before and after dose limit regulation changes10.1088/1361-6498/ad6f19 ↗
55. Physician-received scatter radiation with angiography systems used for interventional radiology: Comparison among many X-ray systems10.1093/rpd/ncr312 ↗